Nobel Prize Workstation
We place strong emphasis on scientific and technological research and actively attract top talent from both domestic and international markets.
Expert Team
Sinocell places great emphasis on scientific research and technological innovation, actively attracting top talent from both China and abroad. The company has been selected for Ningbo’s “3315” Talent Program and has built a scientific team composed of “Academicians + PhDs, Nobel Laureates + Provincial Thousand Talents.” It has been approved as Ningbo’s first Nobel Laureate Academician Workstation, promoting the localization and development of high-caliber talent and high-quality projects in China.
Hu Qirui
Master’s degree from the Institute of Genetics, Chinese Academy of Sciences; PhD from the University of Hawaiʻi; Postdoctoral researcher at the University of California, Santa Barbara.
Deputy Director of the Cell Culture Laboratory, School of Life Sciences, Wuchang University of Technology. Area of Expertise: Primarily engaged in research in molecular biology and cell biology, including human embryonic stem cells, cell recombination, and nanoparticle-based stem cell transfection systems
Doctor of Cell Biology
SDM / Senior R&D Manager
Randy W. Schekman
201Winner of the 2013 Nobel Prize in Physiology or Medicine; American cell biologist; Member of the U.S. National Academy of Sciences; Professor at the University of California, Berkeley.
Sinocell is the only enterprise in China for which Randy Schekman provides consulting services on stem cell and exosome research.
Nobel Prize Laureate
CSA / Chief Scientific Advisor
Jean Krutmann
Member of the German Academy of Sciences;
Lifetime Professor at Heinrich Heine University Düsseldorf;
Leading authority in environmental medicine and skin aging;
Recipient of a Provincial Talent Introduction Program;
Selected for the Municipal “3315 Series Program” (Hai’ou Talent).
Academician
CMO / Chief Medical Officer
Wang Zhigang
20 Biomedical Engineer (Class of 201); Senior expert in biocellular drug R&D and regulatory affairs;
Tianjin Municipality Category A Talent;
Recipient of the “Provincial Science and Technology Progress Award” for three consecutive years.
Bioengineer
SA / Scientific Advisor
Fang Panfeng
Postdoctoral researcher at the Department of Molecular, Cellular and Developmental Biology, Yale University;
PhD from the Max Planck Institute for Developmental Biology;
PhD from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences;
Recipient of the Provincial “Double Innovation Talent” program and an Industry Upgrade Leading Talent.
PhD
CTO / Chief Technology Officer
Liu Hui
PhD from Jilin University; Senior Medical Bioengineering Engineer.
Formerly with the Changchun Institute of Biological Products.
Nearly 20 years of experience in vaccines, cell therapy quality control, and biopharmaceutical QC management; expert in China GMP and regulatory compliance.
PhD
CQO / Chief Quality Officer
Zhou Guangqian
PhD from Umeå University; Professor and doctoral supervisor at the School of Medicine, Shenzhen University.
Adjunct Professor and doctoral supervisor at the State Key Laboratory of Biotherapy, Sichuan University.
Previously held positions at University of Oxford, Queen’s University Belfast, and The University of Hong Kong, as well as Umeå University.
PhD
SA / Scientific Advisor
Qu Xiuxia
PhD in Cell Biology, School of Life Sciences, Peking University;
Postdoctoral researcher in the Department of Molecular Genetics, Indiana University School of Medicine;
Expert at the State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences.
PhD
SA / Scientific Advisor
Prof. Kevin McElwee
Professor of Biomedical Sciences, Faculty of Chemical and Biological Sciences, University of Bradford.
Professor
Member of the Overseas Scientist Team
Prof. Rolf Hoffman
Professor of Dermatology; Scientist at Philipps University of Marburg, Germany; specialist in the histopathology of hair disorders.
Professor
Member of the Overseas Scientist Team
Dr. Petra Goessens
RepliceHead of Clinical and Regulatory Affairs at Replicel;
PhD in Pharmacy from Justus Liebig University Giessen, Germany;
Postdoctoral researcher at INSERM (French National Institute of Health and Medical Research).
PhD
Member of the Overseas Scientist Team
Dr. Rainer Marksteiner
Co-founder of InnovaCell, an Austrian cell therapy biotechnology company;
Former researcher at the Institute of Biochemical Pharmacology, University of Innsbruck;
Degree in Microbiology from Leopold Franzens University;
Doctor of Natural Sciences.
PhD
Member of the Overseas Scientist Team